Literature DB >> 11487072

Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates.

K Tuhkanen1, A Heino, M Ala-Opas.   

Abstract

OBJECTIVE: We compared conventional transurethral electroresection of the prostate (TURP) and hybrid laser treatment in patients with symptomatic bladder outflow obstruction caused by a benign prostate bigger than 40 ml.
MATERIAL AND METHODS: Forty-six patients with symptomatic urodynamically confirmed outflow obstruction caused by benign prostate hyperplasia bigger than 40 ml were accepted to the prospective trial and were randomized to receive hybrid laser treatment or TURP. The hybrid laser technique involved initial non-contact Nd:YAG coagulation followed by contact Nd:YAG vaporization to open the prostatic urethra. Patients were re-assessed after 3, 6, 12 and 24 months.
RESULTS: Of the 46 patients, 37 (80%) were available at the 24-month follow-up. The re-operation rate was 14.3% in the hybrid laser group and 8.3% in the TURP group. The decrease in DanPSS-1 symptom score from baseline at 24 months was 51.0% in the hybrid laser group (p<0.01) and 80.0% in the TURP group (p<0.001), with no statistically significant differences between the groups. Early improvement in objective urinary parameters of peak urinary flow rate and residual urinary volume showed deterioration in hybrid laser group during longer follow-up, whereas in TURP group the improvement of these variables was sustained. Comparison between groups showed TURP to be superior in peak urinary flow rate (p < 0.001) and residual urinary volume (p < 0.01) at the 24-month follow-up visit.
CONCLUSIONS: Both hybrid laser treatment and TURP give good symptomatic relief lasting at least 2 years in the treatment of big obstructing prostates, but hybrid laser treatment is associated with a higher re-operation rate because of inadequate initial prostate tissue removal and with inferior outcome in objective urinary parameters compared with TURP.

Entities:  

Mesh:

Year:  2001        PMID: 11487072     DOI: 10.1080/003655901750291962

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  5 in total

Review 1.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 2.  Urethral stricture following endoscopic prostate surgery: a systematic review and meta-analysis of prospective, randomized trials.

Authors:  Giacomo Maria Pirola; Daniele Castellani; Ee Jean Lim; Marcelo Langer Wroclawski; Dong Le Quy Nguyen; Marilena Gubbiotti; Emanuele Rubilotta; Vinson Wai-Shun Chan; Mariela Corrales; Esther García Rojo; Thomas R W Herrmann; Jeremy Yuen-Chun Teoh; Vineet Gauhar
Journal:  World J Urol       Date:  2022-02-13       Impact factor: 4.226

3.  Bladder neck stenosis after transurethral prostate surgery: a systematic review and meta-analysis.

Authors:  Daniele Castellani; Marcelo Langer Wroclawski; Giacomo Maria Pirola; Vineet Gauhar; Emanuele Rubilotta; Vinson Wai-Shun Chan; Bryan Kwun-Chung Cheng; Marilena Gubbiotti; Andrea Benedetto Galosi; Thomas R W Herrmann; Jeremy Yuen-Chun Teoh
Journal:  World J Urol       Date:  2021-05-11       Impact factor: 4.226

4.  Efficacy of bipolar "button" plasma vaporization of the prostate for benign prostatic obstruction, compared to the standard technique.

Authors:  Hamdy Aboutaleb
Journal:  Urol Ann       Date:  2015 Oct-Dec

5.  Open suprapubic versus retropubic prostatectomy in the treatment of benign prostatic hyperplasia during resident's learning curve: a randomized controlled trial.

Authors:  Arie Carneiro; Paulo Sakuramoto; Marcelo Langer Wroclawski; Pedro Herminio Forseto; Alexandre Den Julio; Carlos Ricardo Doi Bautzer; Leonardo Monte Marques Lins; Andre Kataguiri; Fernanda Batistini Yamada; Gabriel Kushiyama Teixeira; Marcos Tobias-Machado; Antonio Carlos Lima Pompeo
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.